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Background: Iron deficiency is the most common micronutrient deficiency worldwide. 
Experimental animal studies suggest that mothers deficient in iron during pregnancy are more 
likely to have offspring who become obese with high blood pressure. C282Y mutation carriers 
are more likely to have higher iron stores.
Methods: We undertook an instrumental variable (IV) analysis, using maternal C282Y as an 
indicator for the mother’s iron status, to examine its association with offspring blood pressure 
(BP), waist circumference (WC), and body mass index (BMI), and compared the results to that 
of ordinary least squares (OLS) regression. Offspring of a sub-cohort of mothers from the UK 
Women’s Cohort Study (UKWCS) were recruited in 2009–2010 (n = 348, mean age = 41 years). 
Their blood pressure, height, and weight were measured at their local general medical practice, 
and they were asked to self-measure their waist circumference. About half were offspring of 
C282Y carriers. Maternal ferritin was used as a biomarker of maternal iron status.
Results: Maternal C282Y was strongly associated with maternal ferritin (mean difference per 
allele = 84 g/L, 95% confidence interval: 31–137, P = 0.002). Using IV analyses, maternal 
ferritin was not linked to offspring’s BP, BMI, or WC. The first stage F-statistic for the strength 
of the instrument was 10 (Kleibergen–Paap rk LM P = 0.009). Maternal ferritin was linked to 
offspring diastolic BP, WC, and BMI in univariable, but not in multivariable OLS analysis. There 
was no difference between the OLS and the IV models coefficients for any of the outcomes 
considered.
Conclusion: We found no association between maternal iron status and adult offspring’s BP 
and adiposity using both multivariable OLS and IV modeling. To our knowledge, this is the 
first study examining this relationship. Further exploration in larger studies that have genetic 
variation assessed in both mother and offspring should be considered.
Keywords: iron, pregnancy, developmental origins, Mendelian randomization
Introduction
Iron deficiency is the leading single nutrient deficiency in the world. Fifty percent of 
pregnant women in developing countries are anemic mostly due to iron deficiency. It is 
the only micronutrient deficiency which is also significantly prevalent in high income 
countries.1 Maternal iron deficiency during pregnancy in animal experiments results in 
the development of obesity and hypertension in offspring despite the offspring having 
normal iron levels throughout postnatal life.2–5 Iron deficiency-induced changes in 
maternal metabolism may have downstream effects on placental structure, endocrine 
and transport placental functions, nutrient interactions, and fetal organ development 
such as reduced kidney nephron number.6 However, association studies of specific 
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nutrient effects in humans are difficult because of the 
likelihood of important confounding by other nutrients or 
dietary characteristics, as well as other lifestyle factors such 
as smoking and alcohol consumption.7
The use of the random assortment of genes from parents 
to offspring provides one method for assessing the causal 
nature of some environmental exposures. This approach, 
known as Mendelian randomization (MR), uses genetic 
variants as instrumental variables (IV) for the environmental 
exposures of interest.8 Genetic variants are not influenced 
by the many lifestyle and environmental characteristics that 
risk factors, such as iron deficiency, are associated with,9 and 
since they are allocated at conception cannot be influenced 
by the later occurrence of disease processes or treatment 
either. Therefore, associations derived from MR analysis 
are less likely to be affected by confounding and reverse 
causality that can bias established multivariable approaches 
to epidemiological association studies.10
Women who carry a C282Y mutation in the HFE gene 
are more likely, in the homozygous state, to suffer from 
hemochromatosis, resulting in iron overload in the liver.11,12 
About 12%–20% of Northern Europeans are heterozygotes 
for this mutation.11 HFE gene mutation carriers are usually 
asymptomatic, however there is evidence that C282Y 
heterozygotes have higher total iron stores reflected by higher 
transferrin saturation levels,13–16 and higher total body iron 
stores reflected by lower transferrin receptor:serum ferritin 
ratios.13 C282Y homozygotes have significantly higher ferritin, 
transferrin saturation and serum iron levels compared to wild 
type individuals.14 In this study, we have used serum ferritin as 
the environmental measure of the exposure of interest; maternal 
iron status, as it is considered the most useful laboratory 
measure of iron status in the absence of inflammation.17
IV analysis uses the proportion of the variation in maternal 
iron status that is explained by C282Y to provide an uncon-
founded estimate of the relationship with offspring outcomes. 
We hypothesize that women who carry the C282Y mutation are 
at lower risk of iron deficiency during pregnancy, and therefore 
their offspring will have on average lower blood pressure and 
adiposity (as indicated by body mass index [BMI] and waist 
circumference [WC]). The aim of this study was to examine 
the relationship between maternal iron status and offspring 
BP and adiposity measures in adulthood, using both ordinary 
multivariable regression and IV regression methods.
Methods
The UK Women’s Cohort Study (UKWCS), which includes 
35,372 women, aged 35–69 years at recruitment across 
England, Wales, and Scotland, was established in 1994. The 
cohort is described in detail elsewhere.18 Approximately 
15,000 women from UKWCS were contacted between 
1999 and 2002 and asked to provide cheek cell samples 
for DNA extraction (Phase II data collection). All subjects 
who were found to be homozygous or heterozygous for the 
C282Y gene mutation were also asked to provide a blood 
sample, to confirm the result from the cheek cell DNA and 
to measure markers of iron status including serum ferritin. 
The method of analysis to detect the mutation is described in 
detail elsewhere.14 In addition, 3000 women were randomly 
selected to act as a control group.14 We have re-contacted 
1416 mothers (identified as reporting having at least one live 
child in the first UKWCS questionnaire) between 2008 and 
2010, of whom 716 were C282Y allele carriers (aa or ag), and 
700 were wild type HFE genotype (gg). The non-exposed in 
this sample were randomly selected from the pool of women 
with one or more children who were tested and found to 
have a wild type genotype. The total number of offspring 
for women contacted in this study was 3376, of whom 1686 
were children to C282Y carrier mothers and 1690 to wild 
type mothers.
The mothers were asked to pass on the study information 
sheet and consent forms to their offspring. The offspring who 
consented to take part in the study were asked to self-measure 
their WC following specific instructions using a tape measure 
supplied in the study pack. Two measurements for each (in 
inches or centimeters) were provided and their mean used in 
all analyses. Height, weight, and BP were measured at each 
participant’s general practice. A standard operating procedure 
for the measurement of height, weight, and BP sheet was 
attached to the GP/practice nurse’s letter and practice staff 
were asked to follow it when taking the measurements. We 
asked for two BP measurements at least 1 minute apart. If the 
first and second measurement differed by more than 5 mmHg 
for either the systolic blood pressure (SBP) or diastolic blood 
pressure (DBP), a third measurement was requested at least 
1 minute after the second measurement. The mean of the two 
or three readings was used in all analyses. Each participant 
was also asked to fill in a lifestyle questionnaire.
Statistical analysis
All analyses were performed using Stata (v 11.0; Stata 
Corporation, College Station, TX). The relationship of 
interest was examined using both ordinary least squares 
(OLS) regression and instrumental variable (IV) regression 
modeling using the ‘ivreg2’ command in Stata. We adjusted 
for clustering of siblings (where there was more than one 
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sibling per mother included in the study) using the ‘robust 
cluster’ command in Stata which computes a cluster-robust 
standard error of the difference in both the OLS and the IV 
analyses.
We used two-stage least square (2sls) as a method of 
estimation for IV regression, with maternal C282Y genotype 
(aa, ag or gg) as the instrument, under an additive model, 
and maternal ferritin as the modifiable risk factor of interest. 
We included SBP, DBP, WC, and BMI, as outcomes. In the 
first stage of the 2SLS model, the regression of maternal 
ferritin on C282Y (instrument) is fitted. In the second stage, 
the outcome is regressed on the predicted values of maternal 
Fn, the coefficient of which is the estimate of the causal 
effect. The standard errors of the second stage parameters 
are appropriately corrected to account for the uncertainty in 
the predicted values of the exposure from the first stage. The 
first stage F-statistic is reported to provide an indicator of the 
instrument strength. Values of 10 and over are taken to be 
sufficient to exclude weak identification using the specified 
instrument (maternal C282Y).19 The weak identification 
F-statistic we used for the IV regression in the case of 
specification of ‘robust cluster’ in the model is based on 
the Kleibergen–Paap rk statistic, the null hypothesis being 
that the estimator is weakly identified by the instrument.20 
Rejecting the null hypothesis indicates that the instrument 
has sufficient strength.20
Child age, maternal age (at Phase II of the UKWCS), and 
child gender were considered confounders and adjusted for 
in the multivariable OLS models. In addition, maternal BMI 
(at Phase II) and maternal social class (as classified according 
to the three category National Statistics Socio-economic 
Classification) were considered confounders and adjusted 
for in the multivariable OLS models with offspring BMI and 
WC as outcomes. Other potential confounding factors such 
as mother’s vegetarian status was tested for association with 
the exposure and offspring’s blood pressure and adiposity, 
and were included in the multivariable OLS model if they 
showed a statistically significant relationship with both.
The two modeling methods used (OLS and IV regression) 
are examining the same association of maternal iron status 
and offspring adiposity and blood pressure outcomes, using 
the difference in SBP, DBP, WC, and BMI per 10 µg/L 
greater maternal serum ferritin. None of the models are 
testing the direct link between the maternal C282Y genotype 
and offspring outcomes. We used 10,000 bootstrapped 
replications to estimate the standard errors of the differences 
between the IV and the multivariable OLS estimates and 
then calculated P-values from these standard errors based 
on normal approximation for the sampling distribution of 
the mean differences.
This study was conducted according to the guidelines 
laid down in the Declaration of Helsinki and all procedures 
involving human subjects were approved by the NHS North 
West Research Ethical Committee (REC reference number 
07/H1010/68). Written informed consent was obtained from 
all subjects.
Results
The characteristics and measurements of the study partici-
pants are described in Tables 1 and 2. Five hundred and sev-
enteen of the original 3376 offspring consented to take part 
(17%), and 348 offspring of 277 mothers completed the study 
(10% of the invited sample, 61% of those who consented). 
Table 1 Offpsring’s characteristics
Number Percentage 95% CI
Body mass index (n = 335) 
 ,25 
 25–29 
 $30
 
214 
88 
33
 
63.9 
26.3 
9.9
 
58.5–69.0 
21.6–31.3 
6.9–13.6
Smoking (n = 340) 
 Current smoker 
 Ex-smoker 
 Never smoked
 
33 
106 
201
 
9.7 
31.2 
59.1
 
6.8–1.3 
26.3–36.4 
53.7–64.4
Alcohol intake (n = 339) 
 Regular 
 Once/week 
 Occasional/never
 
207 
46 
86
 
61.1 
13.6 
25.4
 
55.6–66.3 
10.1–17.7 
20.8–30.4
Marital status (n = 333) 
 Married 
 Single 
 Divorced/separated/widowed
 
105 
115 
33
 
55.6 
34.5 
9.9
 
50.0–60.9 
29.4–39.9 
6.9–13.6
Vegetarian (n = 332) 44 13.3 10.0–17.4
Hypertension  
(self-reported, n = 340)
21 6.2 3.9–9.3
SBP . 140 mmHg (n = 336) 13 3.9 2.1–6.5
DBP . 90 mmHg (n = 336) 7 2.1 0.8–4.2
Any exercise during the week 
 Vigorous (n = 332) 
 Moderate (n = 337) 
 Light (n = 339)
 
197 
259 
315
 
59.5 
76.6 
92.9
 
53.8–64.7 
72.0–81.3 
89.6–95.4
Self-reported occupation  
(n = 286) 
 Professional/senior managers 
 Intermediate/technical 
 Routine/semi-routine manual 
 Self-employed 
 Student 
 Unemployed
 
 
165 
54 
15 
41 
9 
2
 
 
57.7 
18.9 
5.2 
14.3 
3.2 
0.7
 
 
51.7–63.5 
14.5–24.1 
3.0–8.5 
10.5–18.9 
1.4–5.9 
0.08–2.5
Self-reported low birthweight 
(,2500 g) (n = 230)
15 6.5 3.7–10.5
Abbreviations: CI, confidence interval; DBP, diastolic blood pressure; 
SBP, systolic blood pressure.
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One hundred and seventy (49%) were children of C282Y 
mutation genotype mothers, of whom 12 were children of 
11 homozygotes mothers (aa), and 158 were children of 
heterozygous mothers (ag). Two hundred and forty-seven 
(71%) were females and 101 (29%) were males. The mean 
age was 41 years for women (95% confidence intervals 
[CI]: 40–41) and 40 years (95% CI: 38–42) for men. All 
participants who reported ethnicity information (n = 335) 
described their ethnic group as white. Two hundred and 
twelve offspring had no other siblings, 117 had one sibling 
included in the study, 15 had two siblings, and four had three 
siblings included. Four percent (n = 13) had systolic, and 2% 
(n = 7) had diastolic hypertension, according to the WHO 
cutoff points of 140/90 mmHg.21 Figure 1 shows the average 
offspring BP, WC, and BMI for each maternal genotype.
Maternal serum ferritin was associated with maternal 
age, offspring age, maternal and offspring vegetarian status, 
but there was no statistical evidence that maternal C282Y 
genotype was associated with any of these factors (Table 3). 
Maternal C282Y was strongly associated with maternal Fn: 
mean difference per each additional allele = 84 g/L (95% 
CI: 31–137, P = 0.002). In univariable analysis, maternal 
ferritin was linked to offspring’s DBP (0.1 mmHg for every 
10 µg/L increase in maternal ferritin, 95% CI: 0.03–0.3, 
P = 0.02), offspring WC (0.2 cm for every 10 µg/L increase 
in maternal ferritin, 95% CI: 0.06–0.3, P = 0.006), and 
offspring’s BMI (0.05 kg/m2 for every 10 µg/L increase in 
maternal ferritin, 95% CI: 0.002–0.1, P = 0.04). There were 
no differences in mean offspring BP, WC, and BMI between 
C282Y carriers (aa, ag) and wild type mothers (gg) (results 
not shown). Maternal vegetarian status was significantly 
linked to both maternal ferritin and offspring DBP, and 
therefore was additionally entered in the multivariable OLS 
model with DBP as the outcome.
Table 4 shows the results of associations of maternal 
Fn with each offspring outcome from both the confounder-
adjusted multivariable analyses and the IV analyses using 
maternal C282Y as the instrument. The first stage F-statistic 
for the strength of the instrument in the IV analysis was 10, 
and the Kleibergen–Paap rk LM P-value was 0.009 for all 
outcomes considered. There was no relationship between 
maternal serum ferritin and offspring BP, WC, or BMI 
using both methods. There was also no significant difference 
between the OLS and the IV analyses regression coefficients 
for any of the outcomes considered.
Discussion
We have examined the association of maternal iron status with 
adult offspring’s BP, BMI, and WC. We have compared two 
methods; confounder-adjusted multivariable analyses, and 
analyses where we used a genetic mutation (C282Y) in the 
HFE gene as an instrumental variable for maternal iron status. 
We have found that maternal iron status was not associated 
with the three offspring outcomes considered in this study 
using either method. There was also no statistical evidence 
that the associations differed between these two statistical 
approaches. In our sample, maternal C282Y genotype was 
associated with ferritin level. This supports our hypothesis 
that HFE C282Y could be used as an instrumental variable 
for iron status.
There are two published studies examining the relationship 
of maternal iron intake and hemoglobin levels in pregnancy 
with children’s blood pressure at 3 and 7 years of age.22,23 
However, to our knowledge, there are no previous studies 
examining the relationship of maternal iron status with adult 
offspring blood pressure and adiposity using either approach 
(OLS or MR). Belfort et al reported a positive, rather than 
an inverse, association between maternal iron intake in 
pregnancy and child SBP at 3 years,23 while Brion et al 
found no association.22 However, iron intake in pregnancy 
is not considered a good indicator of iron status, as this 
largely depends on women’s iron reserves before pregnancy. 
Table 2 Offspring’s measurements
Mean SD 95% CI Median
Height (n = 335) 
 F 
 M
169.3 
165.2 
179.7
9.8 
7.0 
8.1
168.3–170.4 
164.3–166.1 
178.1–181.4
168 
165 
179
Weight (n = 338) 
 F 
 M
70.0 
65.5 
80.9
14.3 
12.1 
13.3
68.5–71.5 
78.2–83.5 
64.0–67.1
66.7 
64.0 
79.8
BMI (n = 335) 
 F 
 M
24.3 
24.0 
25.0
4.2 
4.3 
3.9
23.9–24.8 
23.5–24.6 
24.2–25.8
23.6 
23.3 
24.6
SBP (n = 336) 
 F 
 M
116.5 
113.6 
123.5
13.6 
12.6 
13.5
115.0–117.9 
112.0–115.2 
120.8–126.2
116.0 
113.0 
122.5
DBP (n = 336) 
 F 
 M
72.7 
71.4 
76.0
9.2 
8.7 
9.7
71.8–73.7 
70.3–72.5 
74.0–77.9
72.0 
71.0 
76.0
Waist circumference (n = 341) 
 F 
 M
83.2 
80.5 
89.7
12.4 
11.3 
12.7
81.9–84.5 
79.1–81.9 
87.2–92.2
81.3 
78.3 
89.5
Hip circumference (n = 342) 
 F 
 M
98.9 
98.9 
99.0
10.1 
10.1 
10.1
97.9–100.0 
97.6–100.2 
97.0–101.0
98.5 
97.5 
100
Waist/hip ratio (n = 341) 
 F 
 M
0.84 
0.81 
0.91
0.09 
0.07 
0.11
0.83–0.85 
0.81–0.82 
0.89–0.93
0.83 
0.81 
0.91
Abbreviations: BMI, body mass index; CI, confidence interval; DBP, diastolic blood 
pressure; SBP, systolic blood pressure, F, female; M, male.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
196
Alwan et al
Clinical Epidemiology 2012:4
Fortified foods may have the potential to reduce micronutrient 
deficiencies including iron during pregnancy.25 However, 
a study in Denmark found that 40% of women of child-
bearing age had low iron status despite having a national 
iron fortification program of flour.26
Study strengths and weaknesses
A key strength of this study is that it is the first to examine 
the association of maternal iron status with offspring blood 
pressure and adiposity in a human population. Thus, we have 
taken observations from previous animal work2–5 into a human 
population. We have used serum ferritin as a measure of iron 
status, as there is evidence that ferritin alone provides a good 
Table 3 Univariable P-values of the association between maternal 
serum ferritin and maternal C282Y with potential confounders 
in the relationship between maternal iron status and offspring 
outcomes
Maternal ferritin Maternal C282Y
Maternal age ,0.0001 0.9
Offspring age ,0.0001 0.9
Offspring gender 0.3 0.4
Maternal vegetarian status ,0.0001 0.8
Offspring vegetarian status 0.003 0.9
Maternal smoking 0.1 0.1
Maternal social class 0.5 0.9
Maternal BMI 0.2 0.8
Abbreviation: BMI, body mass index.
130
120
110
100
90
80
70
60
50
40
30
10
20
0
aa (n = 12) 122.6
SBP (mmHg) DBP (mmHg) BMI (kg/m2) WC (cm)
117.1
115.5
76
73.2
72.1
26
24.5
24
89.2
82.9
83.1
ag (n = 158)
gg (n = 178)
Figure 1 Mean offspring blood pressure (BP), body mass index (BMI), and waist circumference (WC) per maternal genotype.
approximation of total body iron reserves, as validated by 
transferrin receptor-to-ferritin ratios in people with unelevated 
C-reactive protein.22 There is however, a possibility that this 
approximation may vary in pregnant women.
We have also tried to examine the association using two 
statistical approaches with different underlying assumptions 
for assessing causality that complement each other. The 
multivariable approach assumes that potential confounding 
factors are accounted for, correctly measured and modeled, 
and that there is no possibility of reverse causality. In this 
case, reverse causality is unlikely (ie, we cannot see how 
offspring outcomes could influence the mothers iron status). 
However, residual confounding is still possible with this 
approach.
We did not have information on maternal iron intake 
during pregnancy. We have also used maternal ferritin 
concentration assessed many years after they were pregnant 
with the offspring, and are therefore assuming in these 
analyses that this is a reasonable proxy for maternal iron 
status during pregnancy. Any measurement error is likely to 
be non-differential with respect to the offspring outcomes 
that we have assessed here, and therefore the expectation 
would be that results would be biased towards the null. Thus, 
this measurement error might explain the null multivariable 
observations. For the instrumental variable analyses, 
using maternal iron concentrations outside of pregnancy 
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Table 4 Association of maternal iron status with offspring blood pressure and adiposity measures using maternal C282Y status as an 
instrumental variable
Outcome OLS* mean difference 
in outcome per 10 μg/L greater  
maternal ferritin (95% CI)
IV** regression mean difference  
in outcome per 10 μg/L greater  
maternal ferritin (95% CI)
P-value*** 
for the difference in  
regression coefficients
Systolic BP 
(SBP) (mmHg)
0.03 (-0.1 to 0.1) 0.2 (-0.2 to 0.6) 0.5
Diastolic BP 
(DBP) (mmHg)
0.04 (-0.07 to 0.2) 0.2 (-0.07 to 0.5) 0.6
Body mass index  
(BMI) (kg/m2)
0.02 (-0.02 to 0.07) 0.1 (-0.03 to 0.2) 0.5
Waist circumference 
(WC) (cm)
0.1 (0 to 0.2) 0.07 (-0.3 to 0.5) 0.9
Notes: *Multivariable ordinary least squares models adjusted for maternal age, child age, and gender in all models, and additionally for maternal vegetarian status in the DBP 
model, and maternal BMI and social class (NS-SEC) in the BMI and WC models; **instrumental variable two-stage least squares (2SLS), first stage F-statistic = 10; ***derived 
using 10,000 bootstrapped replications to estimate the standard errors of the differences between the IV and multivariable OLS regression estimates.
Abbreviations: CI, confidence interval; IV, instrumental variable; OLS, ordinary least squares.
is not a major limitation as the genetic variant will have 
resulted in subtle differences in iron status throughout 
the woman’s lifecourse including during pregnancy. This 
approach is also less influenced by residual confounding. 
However, the instrumental variable analysis assumes that 
the instrument is associated with the risk factor of interest, 
which we know is the case from previous studies and 
which we have demonstrated here, though the first stage 
F-statistic of 10 suggests that the instrument’s strength to 
identify the estimator (maternal ferritin) is borderline.19 
This would bias the instrumental variable analysis towards 
the null results seen in the multivariable analysis. Using 
another measure of iron stores during pregnancy, such as 
transferrin receptor-to-ferritin ratio, which is not affected by 
inflammation, could strengthen the genetic instrument.
It is further assumed that the instrumental variable (for this 
study, the C282Y mutation in the HFE gene) is not associated 
with any measured or unmeasured confounding, ie, it is 
naturally randomized in the population. This is confirmed by 
testing the association between maternal C282Y and selected 
measured factors in our data as shown in Table 3. However, 
one of the conditions of IV analysis is that the instrument 
should not be related to the outcome except through 
the exposure of interest (Z related to Y only through X). 
The fact that maternal genotype is linked to offspring 
genotype may constitute a violation to this assumption. This 
would be the case in all transgenerational studies that attempt 
to use a MR design. The ideal way to tackle this problem 
would be to measure offspring genotype and adjust for it. One 
of the main limitations in this study is that offspring genotype 
was not measured. There is some evidence linking C282Y 
heterozygotes with an increased risk of cardiovascular (CV) 
disease.27,28 However, other studies show no association.29,30 
If there is a true positive relationship between offspring 
genotype and their BP, this may counteract an inverse 
relationship between maternal genotype (used as a proxy 
for maternal iron status here) and offspring’s BP, potentially 
leading to a spurious non-association in the relationship of 
interest. However, it could be argued that it is the iron status 
at the time of gestation that is the contributing factor to CV 
risk, and not the phenotype of the fetus.
The study’s response rate of 10% meant that the study had 
a smaller sample size than initially planned. MR studies require 
sample sizes larger than classical epidemiological studies due 
to reduced precision of the estimates as genotype usually only 
explains a proportion of the variation in the environmental 
exposure of interest. The relatively poor response rate may 
be due to the indirect recruitment methods used (through 
mothers), as well as the necessity of visiting the GP.
Conclusion
We found no association between maternal iron status and 
offspring’s blood pressure and adiposity using both multi-
variable ordinary least squares regression and instrumental 
variable modeling with maternal C282Y mutation in the 
HFE gene as the instrument. However, the relatively small 
study sample for a MR design and the lack of measurement 
of the offspring C282Y genotype in order to adjust for any 
possible effect on the relationship of interest are likely to 
push the study results towards accepting the null hypothesis. 
Therefore, replication of findings in studies that avoid these 
limitations should be considered.
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